In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-PocketOffering PrEP to everyone who receives PEPCurrently recommended PrEP options and the safety and adverse event considerations with each optionMonitoring recommendations for the different PrEP optionsThe importance of proactively addressing PrEP safety concerns that could lead to PrEP discontinuationFacultyKevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCESAssistant ProfessorPharmacotherapeutics and Clinical ResearchUniversity of South Florida Taneja College of MedicineTampa, FloridaFollow along with the slides:bit.ly/48cULUNLink to full program:bit.ly/3ZlICsL Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related